Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ahmad Ghorbani Vanan
Observed names:
Ahmad Ghorbani,
Ahmad Ghorbani vanan,
Ghorbani Vanan Ahmad
Institutions:
Ardabil University of Medical Sciences,
Shahid Beheshti University,
Shahid Beheshti University of Medical Sciences
Observed institutions:
Ardabil University of Medical Sciences,
Shahid Beheshti University,
Shahid Beheshti University of Medical Sciences,
Tehran University of Medical Sciences
ORCID:
0000-0003-3688-3178
Observed ORCID:
0000-0003-3688-3178
OpenAlex ID:
A5114436389
Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?
2024
·
Milad Taghizadeh Anvar
, Kimiya Rashidan
, et al.
·
Cancer Cell International
·
76
SARS‐CoV‐2 nucleocapsid: Biological functions and implication for disease diagnosis and vaccine design
2023
·
Faezeh Maghsood
, Ahmad Ghorbani
, et al.
·
Reviews in Medical Virology
·
26
PDF
The tumor microenvironment and dendritic cells: Developers of pioneering strategies in colorectal cancer immunotherapy?
2025
·
Farid Ghorbaninezhad
, Mina Afrashteh Nour
, et al.
·
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
·
25
Diagnostic performance of a novel antigen-capture ELISA for the detection of SARS-CoV-2
2023
·
Hamidreza Yadegari
, Mehdi Mohammadi
, et al.
·
Analytical Biochemistry
·
21
PDF
Macrophage polarization in hepatocellular carcinoma: a lncRNA-centric perspective on tumor progression and metastasis
2025
·
Ahmad Ghorbani vanan
, Mohammad Taha Nami
, et al.
·
Clinical and Experimental Medicine
·
19
PDF
Immune checkpoint inhibition in renal cell carcinoma: Mechanisms of resistance and emerging therapeutic strategies
2025
·
Ali Darzi
, Mahla Shokouhfar
, et al.
·
Biomedicine & Pharmacotherapy
·
15
Neurologic complications of immune checkpoint inhibitors: A comprehensive review
2025
·
Saeed Zivari Lashkajani
, Yasaman Sadat Azad
, et al.
·
Biomedicine & Pharmacotherapy
·
15
PDF
Immunotherapeutic advances in pediatric neuroblastoma: Overcoming resistance through biomarker-guided combinations
2026
·
Mahla Shokouhfar
, Ali Darzi
, et al.
·
Biomedicine & Pharmacotherapy
·
9
A new era in melanoma immunotherapy: focus on DCs metabolic reprogramming
2025
·
Mina Afrashteh Nour
, Mansour Rajabivahid
, et al.
·
Cancer Cell International
·
8
PDF
Long non-coding RNAs: key orchestrators of macrophage polarization in breast cancer
2025
·
Farid Ghorbaninezhad
, Ahmad Ghorbani Vanan
, et al.
·
Cancer Cell International
·
7
PDF
Breaking barriers: CAR-NK cell therapy breakthroughs in female-related cancers
2025
·
Ghorbani Vanan Ahmad
, Samaneh Nouri
, et al.
·
Biomedicine & Pharmacotherapy
·
7
CCAT2 role in gastrointestinal cancer progression and metastasis: a novel target for therapeutic strategies
2025
·
Ahmad Ghorbani Vanan
, Farid Ghorbaninezhad
, et al.
·
Clinical and Experimental Medicine
·
6
PDF
DCLK1 in gastrointestinal cancer: A driver of tumor progression and a promising therapeutic target
2025
·
Ahmad Ghorbani Vanan
, Soheil Vesal
, et al.
·
International Journal of Cancer
·
6
A symphony of signals: the intricate role of lncRNAs in dermatological disorders
2025
·
Ahmad Ghorbani Vanan
, Samaneh Nouri
, et al.
·
Clinical and Experimental Medicine
·
4
PDF
The CCAT2 enigma: pioneering insights into colorectal cancer pathophysiology and therapeutic innovation
2025
·
Maryam Fathollahzadeh
, Ahmad Ghorbani Vanan
, et al.
·
Cancer Cell International
·
3
Novel neutralizing mouse-human chimeric monoclonal antibodies against the SARS-CoV-2 receptor binding domain
2023
·
Ahmad Ghorbani
, Faezeh Maghsood
, et al.
·
Journal of Medical Microbiology
·
3
Immunotherapy in hepatocellular carcinoma: translating mechanistic insights into clinical advances
2026
·
Saeed Khavari Khorasani
, Siavash Boroumandi
, et al.
·
Clinical and Experimental Medicine
·
2
Corrigendum to “Immune checkpoint inhibition in renal cell carcinoma: Mechanisms of resistance and emerging therapeutic strategies” [Biomed. Pharmacother. 193 (2025) 118875]
2026
·
Ali Darzi
, Mahla Shokouhfar
, et al.
·
Biomedicine & Pharmacotherapy
·
2
Harnessing the potential of CAR-NK cell therapy in gastrointestinal cancers: From bench to bedside
2025
·
Ahmad Ghorbani Vanan
, Mohammad Reza Askari
, et al.
·
Biomedicine & Pharmacotherapy
·
2
Production and characterization of a panel of anti-mouse placenta-specific protein 1 (plac1) monoclonal antibodies
2024
·
Sahar Mortezagholi
, Faezeh Maghsood
, et al.
·
Analytical Biochemistry
·
2
LncRNA CCAT2 role in female-related cancer progression and diagnosis: a comprehensive review
2026
·
Ahmad Ghorbani Vanan
, Farnaz Hassanzadeh
, et al.
·
Clinical and Experimental Medicine
·
1
PDF
Macrophage polarization and non-coding RNAs in colorectal cancer progression and metastasis
2026
·
Mohammad Taha Nami
, Iliya Fattahiyan
, et al.
·
Medical Oncology
Current evidence supports evaluation of CCAT2 in prostate cancer progression biomarker development and treatment resistance
2026
·
Safa Tahmasebi
, Ahmad Ghorbani Vanan
, et al.
·
Discover Oncology
Corrigendum to “Immunotherapeutic advances in pediatric neuroblastoma: Overcoming resistance through biomarker-guided combinations”, [Biomed. Pharmacother. 196 (2026) 119020]
2026
·
Mahla Shokouhfar
, Ali Darzi
, et al.
·
Biomedicine & Pharmacotherapy
PDF
Genetically engineered dendritic cells in cancer immunotherapy: from immune reprogramming strategies to emerging CAR-DC platforms
2026
·
Farid Ghorbaninezhad
, Milad Taghizadeh Anvar
, et al.
·
npj Precision Oncology
PDF
Show more works
View as search
Works count:
27
Citation count:
259
H-index:
8
I10-index:
7
Year
Topic
Type
